Literature DB >> 28159161

Atypical Pneumonia: Updates on Legionella, Chlamydophila, and Mycoplasma Pneumonia.

Lokesh Sharma1, Ashley Losier2, Thomas Tolbert3, Charles S Dela Cruz1, Chad R Marion4.   

Abstract

Community-acquired pneumonia (CAP) has multiple causes and is associated with illness that requires admission to the hospital and mortality. The causes of atypical CAP include Legionella species, Chlamydophila, and Mycoplasma. Atypical CAP remains a diagnostic challenge and, therefore, likely is undertreated. This article reviews the advancements in the evaluation and treatment of patients and discusses current conflicts and controversies of atypical CAP.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chlamydophila; Community-acquired pneumonia (CAP); Legionella; Legionnaires’ disease; Mycoplasma; Pontiac fever; Walking pneumonia

Mesh：

Year:  2016        PMID： 28159161      PMCID： PMC5679202          DOI： 10.1016/j.ccm.2016.11.011

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN： 0272-5231            Impact factor:   2.878


  98 in total

1.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

2.  High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China.

Authors:  Bin Cao; Chun-Jiang Zhao; Yu-Dong Yin; Fei Zhao; Shu-Fan Song; Lu Bai; Jian-Zhong Zhang; Ying-Mei Liu; Yu-Yu Zhang; Hui Wang; Chen Wang
Journal:  Clin Infect Dis       Date:  2010-07-15       Impact factor: 9.079

3.  Intravenous azithromycin as salvage therapy in a patient with Legionnaire's disease.

Authors:  L Dorrell; B Fulton; E L Ong
Journal:  Thorax       Date:  1994-06       Impact factor: 9.139

4.  Impact of infectious etiology on the outcome of Taiwanese patients hospitalized with community acquired pneumonia.

Authors:  Yuan-Ti Lee; Shiuan-Chih Chen; Kuei-Chuan Chan; Tzu-Chin Wu; Shih-Ming Tsao; Chi-Ho Chan
Journal:  J Infect Dev Ctries       Date:  2013-02-15       Impact factor: 0.968

5.  Activity of finafloxacin, a novel fluoroquinolone with increased activity at acid pH, towards extracellular and intracellular Staphylococcus aureus, Listeria monocytogenes and Legionella pneumophila.

Authors:  Sandrine Lemaire; Françoise Van Bambeke; Paul M Tulkens
Journal:  Int J Antimicrob Agents       Date:  2011-05-18       Impact factor: 5.283

6.  [Mycoplasma-related pneumonia: a rare cause of acute respiratory distress syndrome (ARDS) and of potential antibiotic resistance].

Authors:  B Sztrymf; F Jacobs; J Fichet; O Hamzaoui; D Prat; A Avenel; C Richard
Journal:  Rev Mal Respir       Date:  2012-10-16       Impact factor: 0.622

7.  Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012.

Authors:  Fei Zhao; Gang Liu; Jiang Wu; Bin Cao; Xiaoxia Tao; Lihua He; Fanliang Meng; Liang Zhu; Min Lv; Yudong Yin; Jianzhong Zhang
Journal:  Antimicrob Agents Chemother       Date:  2012-12-21       Impact factor: 5.191

8.  Immunoproteomic identification and serological responses to novel Chlamydia pneumoniae antigens that are associated with persistent C. pneumoniae infections.

Authors:  Sebastian Bunk; Iuliana Susnea; Jan Rupp; James T Summersgill; Matthias Maass; Werner Stegmann; André Schrattenholz; Albrecht Wendel; Michael Przybylski; Corinna Hermann
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

9.  Mycoplasma pneumoniae pneumonia in children.

Authors:  You-Sook Youn; Kyung-Yil Lee
Journal:  Korean J Pediatr       Date:  2012-02-14

10.  Legionella pneumophila strain associated with the first evidence of person-to-person transmission of Legionnaires' disease: a unique mosaic genetic backbone.

Authors:  Vítor Borges; Alexandra Nunes; Daniel A Sampaio; Luís Vieira; Jorge Machado; Maria J Simões; Paulo Gonçalves; João P Gomes
Journal:  Sci Rep       Date:  2016-05-19       Impact factor: 4.379
View more
  19 in total

Review 1.  Rifamycin antibiotics and the mechanisms of their failure.

Authors:  Rebekah A Adams; Gabrielle Leon; Natalia M Miller; Saira P Reyes; Chantal H Thantrong; Alina M Thokkadam; Annabel S Lemma; Darshan M Sivaloganathan; Xuanqing Wan; Mark P Brynildsen
Journal:  J Antibiot (Tokyo)       Date:  2021-08-16       Impact factor: 2.649

2.  Legionnaire's Disease Presenting With the Legionella Triad (Pneumonia, Rhabdomyolysis, and Renal Failure) and Cardiac Complications.

Authors:  Arjun Prasanna; Justin Palmer; Sharon Wang
Journal:  Cureus       Date:  2022-06-18

3.  Distribution characteristics of serum β2-microglobulin between viral and bacterial lower respiratory tract infections: a retrospective study.

Authors:  Xulong Cai; Qiaolan Xu; Chenrong Zhou; Li Zhou; Qijun Yong; Qing Mu; Yan Cheng; Jiena Wang; Jingjing Xie
Journal:  PeerJ       Date:  2020-08-25       Impact factor: 2.984

Review 4.  Spectrum of imaging findings in pulmonary infections. Part 1: Bacterial and viral.

Authors:  Mandeep Garg; Nidhi Prabhakar; Ajay Gulati; Ritesh Agarwal; Sahajal Dhooria
Journal:  Pol J Radiol       Date:  2019-04-18

Review 5.  Pharmacotherapy of Lower Respiratory Tract Infections in Elderly-Focused on Antibiotics.

Authors:  Yang Liu; Yan Zhang; Wanyu Zhao; Xiaolei Liu; Fengjuan Hu; Birong Dong
Journal:  Front Pharmacol       Date:  2019-10-31       Impact factor: 5.810

6.  Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study.

Authors:  Stephanie W Lo; Rebecca A Gladstone; Andries J van Tonder; John A Lees; Mignon du Plessis; Rachel Benisty; Noga Givon-Lavi; Paulina A Hawkins; Jennifer E Cornick; Brenda Kwambana-Adams; Pierra Y Law; Pak Leung Ho; Martin Antonio; Dean B Everett; Ron Dagan; Anne von Gottberg; Keith P Klugman; Lesley McGee; Robert F Breiman; Stephen D Bentley
Journal:  Lancet Infect Dis       Date:  2019-06-10       Impact factor: 71.421

7.  [Non-pneumococcal bacterial pneumonias (II). Respiratory infections by Mycoplasma and Chlamydia. Viral pneumonias].

Authors:  J A Quiles Machado; V Aragón Domínguez; M Monsalvo Hernando; M Gómez Durán
Journal:  Medicine (Madr)       Date:  2018-04-21

8.  Differential effects of the Akt pathway on the internalization of Klebsiella by lung epithelium and macrophages.

Authors:  Jingjing Feng; Hongbo Liu; Wei Liu; Lokesh Sharma; Charles S Dela Cruz
Journal:  Innate Immun       Date:  2020-08-06       Impact factor: 2.680

9.  Frequency of Mycoplasma pneumoniae, Legionella pneumophila and Chlamydia spp. among patients with atypical pneumonia in Tehran.

Authors:  N Noori Goodarzi; M R Pourmand; M Rajabpour; M Arfaatabar; M Mosadegh; S A Syed Mohamad
Journal:  New Microbes New Infect       Date:  2020-08-14

10.  Current perspectives on atypical pneumonia in children.

Authors:  Jung Yeon Shim
Journal:  Clin Exp Pediatr       Date:  2020-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.